Iminophenimide

This classification denotes a sedative and hypnotic with the molecular formula C12H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0X939RX9W, chemically known as 3-ethyl-3-phenyl-2,6-piperazindion but generally known as iminophenimide, which bears US NIH Compound Identifier 163317. European Medicines Agency schedules Iminophenimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08150MIG. The term IMINOPHENIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). IMINOPHENIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iminophenimide under HS 29335995 and SITC 51576. As of Q4 2014, IMINOPHENIMIDE remains the US FDA Preferred Term for this commodity. Iminophenimide bears US NLM identifiers UMLS ID C2826568 and NCI Concept Code C82923. SMILES: CCC1(C(=O)NC(=O)CN1)C2=CC=CC=C2.